Pneumonia immunization in older adults: review of vaccine effectiveness and strategies

References

• SilvermanMEMurrayTJBryanCSThe Quotable OslerPhiladelphiaAmerican College of Physicians1998139
   Google Scholar
• HeronMTejada-VeraBDeaths: leading causes for 2005Natl Vital Stat Rep200958819720361522
   PubMedGoogle Scholar
• SimonsenLReichertTAViboudCBlackwelderWCTaylorRJMillerMAImpact of influenza vaccination on seasonal mortality in the US elderly populationArch Intern Med2005165326527215710788
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionEstimates of deaths associated with seasonal influenza – United States, 1976–2007MMWR Morb Mortal Wkly Rep201059331057106220798667
   PubMedGoogle Scholar
• BeigelJHInfluenzaCrit Care Med20083692660266618679129
   PubMed Web of Science ®Google Scholar
• ThomasCPRyanMChapmanJDIncidence and cost of pneumonia in Medicare beneficiariesChest Epub March 8, 2012
   Web of Science ®Google Scholar
• FedsonDSMusherDMPneumococcal polysaccharide vaccinePlotkinSAOrensteinWAVaccinesPhiladelphiaSaunders2003529588
   Google Scholar
• SankilampiUHonkanenPOBloiguAHervaELeinonenMAntibody response to pneumococcal capsular polysaccharide vaccine in the elderlyJ Infect Dis199617323873938568300
   PubMed Web of Science ®Google Scholar
• LaiCCLeeLNYuCJAntibody responses to pneumococcal polysaccharide vaccine in Taiwanese patients with chronic obstructive pulmonary diseaseJ Formos Med Assoc2007106319620317389163
   PubMed Web of Science ®Google Scholar
• SchenkeinJGParkSNahmMHPneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potencyVaccine200826435521552618706464
   PubMed Web of Science ®Google Scholar
• RubinsJBPuriAKLochJMagnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adultsJ Infect Dis199817824314409697723
   PubMed Web of Science ®Google Scholar
• Romero-SteinerSMusherDMCetronMSReduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidityClin Infect Dis199929228128810476727
   PubMed Web of Science ®Google Scholar
• OrtqvistAPneumococcal vaccination: current and future issuesEur Respir J200118118419511510792
   PubMed Web of Science ®Google Scholar
• MusherDMManofSBLissCSafety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adultsJ Infect Dis2010201451652420092407
   PubMed Web of Science ®Google Scholar
• ManoffSBLissCCaulfieldMJRevaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = yearsJ Infect Dis2010201452553320088694
   PubMed Web of Science ®Google Scholar
• O’BrienKLHochmanMGoldblattDCombined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?Lancet Infect Dis20077959760617714673
   PubMed Web of Science ®Google Scholar
• de RouxASchmole-ThomaBSiberGRComparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memoryClin Infect Dis20084671015102318444818
   PubMed Web of Science ®Google Scholar
• MoberleySAHoldenJTathamDPAndrewsRMVaccines for preventing pneumococcal infection in adultsCochrane Database Syst Rev20081CD00042218253977
   PubMed Web of Science ®Google Scholar
• ShapiroEDClemensJDA controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infectionsAnn Intern Med198410133253306380367
   PubMed Web of Science ®Google Scholar
• SimsRVSteinmannWCMcConvilleJHKingLRZwickWCSchwartzJSThe clinical effectiveness of pneumococcal vaccine in the elderlyAnn Intern Med198810856536573358567
   PubMed Web of Science ®Google Scholar
• MelegaroAEdmundsWJThe 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analysesEur J Epidemiol200419435336315180106
   PubMed Web of Science ®Google Scholar
• KaufmanPPneumonia in old age; active immunization against pneumonia with pneumonococcus polysaccharide; results of a six year studyArch Intern Med1947795518531
   Google Scholar
• GaillatJZmirouDMallaretMRClinical trial of an antipneumococcal vaccine in elderly subjects living in institutionsRev Epidemiol Sante Publique1985336437444 French3914014
   PubMed Web of Science ®Google Scholar
• HonkanenPOKeistinenTMiettinenLIncremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or olderVaccine19991720–212493250010418894
   PubMed Web of Science ®Google Scholar
• Vila-CorcolesAOchoa-GondarOHospitalIProtective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 studyClin Infect Dis200643786086816941367
   PubMed Web of Science ®Google Scholar
• Vila-CorcolesASalsenchERodriguez-BlancoTClinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control studyVaccine200927101504151019171174
   PubMed Web of Science ®Google Scholar
• JacksonLANeuzilKMYuOEffectiveness of pneumococcal polysaccharide vaccine in older adultsN Engl J Med2003348181747175512724480
   PubMed Web of Science ®Google Scholar
• JohnstoneJEurichDTMinhasJKMarrieTJMajumdarSRImpact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumoniaClin Infect Dis2010511152220504233
   PubMed Web of Science ®Google Scholar
• RileyIDLehmannDAlpersMPMarshallTFGrattenHSmithDPneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean childrenLancet1986285128778812876325
   PubMed Web of Science ®Google Scholar
• WagnerCPoppWPoschMVlasichCRosenberger-SpitzyAImpact of pneumococcal vaccination on morbidity and mortality of geriatric patients: a case-controlled studyGerontology200349424625012792160
   PubMed Web of Science ®Google Scholar
• MelegaroAEdmundsWJThe 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and WalesEur J Epidemiol200419436537515180107
   PubMed Web of Science ®Google Scholar
• SimberkoffMSCrossAPAl-IbrahimMEfficacy of pneumococcal vaccine in high-risk patients Results of a Veterans Administration Cooperative StudyN Engl J Med198631521131813273534568
   PubMed Web of Science ®Google Scholar
• AustrianRSurveillance of Pneumococcal Infection for Field Trials of Polyvalent Pneumococcal VaccinesBethesdaNational Institutes of Health1980
   Google Scholar
• KawakamiKOhkusaYKurokiREffectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in JapanVaccine201028437063706920723631
   PubMed Web of Science ®Google Scholar
• MaruyamaTTaguchiONiedermanMSEfficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trialBMJ2010340c100420211953
   PubMed Web of Science ®Google Scholar
• KoivulaIStenMLeinonenMMakelaPHClinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trialAm J Med199710342812909382120
   PubMed Web of Science ®Google Scholar
• OrtqvistAHedlundJBurmanLARandomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study GroupLancet199835191003994039482293
   PubMed Web of Science ®Google Scholar
• AlfagemeIVazquezRReyesNClinical efficacy of anti-pneumococcal vaccination in patients with COPDThorax200661318919516227328
   PubMed Web of Science ®Google Scholar
• HirschmannJVLipskyBAThe pneumococcal vaccine after 15 years of useArch Intern Med199415443733778117169
   PubMedGoogle Scholar
• JacksonLAJanoffENPneumococcal vaccination of elderly adults: new paradigms for protectionClin Infect Dis200847101328133818844484
   PubMed Web of Science ®Google Scholar
• DearKHoldenJAndrewsRTathamDVaccines for preventing pneumococcal infection in adultsCochrane Database Syst Rev20034CD00042214583920
   PubMedGoogle Scholar
• HussAScottPStuckAETrotterCEggerMEfficacy of pneumococcal vaccination in adults: a meta-analysisCMAJ20091801485819124790
   PubMed Web of Science ®Google Scholar
• ArguedasASoleyCAbdelnourAPrevenar experienceVaccine201129Suppl 3C26C3421896350
   PubMedGoogle Scholar
• DaganRGradsteinSBelmakerIAn outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern IsraelClin Infect Dis200030231932110671335
   PubMed Web of Science ®Google Scholar
• RomneyMGHullMWGustafsonRLarge community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban populationClin Infect Dis200847676877418690803
   PubMed Web of Science ®Google Scholar
• HausdorffWPThe roles of pneumococcal serotypes 1 and 5 in paediatric invasive diseaseVaccine200725132406241217055620
   PubMed Web of Science ®Google Scholar
• Prevnar 13 (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein])Philadelphia, PAWyeth Pharmaceuticals2011
   Google Scholar
• Food and Drug AdministrationVaccines and Related Biological Products Advisory Committee (VRBPAC) adult indication briefing document: Prevnar13Silver Spring, MDUS Department of Health and Human Services, Food and Drug Administration2011 Available from: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/vaccinesandrelatedbiologicalproductsadvisorycommittee/ucm279680.pdfAccessed October 12, 2012
   Google Scholar
• Centers for Disease Control and PreventionLicensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and olderMMWR Morb Mortal Wkly Rep2012612139439522647745
   PubMedGoogle Scholar
• HakEGrobbeeDESandersEARationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adultsNeth J Med200866937838318990781
   PubMed Web of Science ®Google Scholar
• PilishviliTLexauCFarleyMMSustained reductions in invasive pneumococcal disease in the era of conjugate vaccineJ Infect Dis20102011324119947881
   PubMed Web of Science ®Google Scholar
• ChoiYHJitMFlascheSGayNMillerEMathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and WalesPloS One201277e3992722808073
   PubMed Web of Science ®Google Scholar
• RubinJLMcGarryLJStruttonDRPublic health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United StatesVaccine201028487634764320883739
   PubMed Web of Science ®Google Scholar
• StuartWHDullHBNewtonLHMcQueenJLSchiffEREvaluation of monovalent influenza vaccine in a retirement community during the epidemic of 1965–1966JAMA196920922322385819227
   PubMed Web of Science ®Google Scholar
• BurneyLEInfluenza immunization: statementPublic Health Rep1960751094419316369
   PubMed Web of Science ®Google Scholar
• LongPHRecommendations for influenza immunization and control: 1964–1965Med Times1964921203120514197263
   PubMedGoogle Scholar
• GovaertTMThijsCTMasurelNSprengerMJDinantGJKnottnerusJAThe efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trialJAMA199427221166116657966893
   PubMed Web of Science ®Google Scholar
• GoodwinKViboudCSimonsenLAntibody response to influenza vaccination in the elderly: a quantitative reviewVaccine20062481159116916213065
   PubMed Web of Science ®Google Scholar
• AllsupSHaycoxAReganMGosneyMIs influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trialVaccine200423563964515542184
   PubMed Web of Science ®Google Scholar
• PraditsuwanRAssantachaiPWasiCPuthavatanaPKositanontUThe efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the communityJ Med Assoc Thai200588225626415962680
   PubMedGoogle Scholar
• TreanorJDInfluenza – the goal of controlN Engl J Med2007357141439144117914046
   PubMed Web of Science ®Google Scholar
• NicholKLChallenges in evaluating influenza vaccine effectiveness and the mortality benefits controversyVaccine200927456305631119840665
   PubMed Web of Science ®Google Scholar
• NordinJMulloolyJPobleteSInfluenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plansJ Infect Dis2001184666567011517426
   PubMed Web of Science ®Google Scholar
• HakEWeiFGrobbeeDENicholKLA nested case-control study of influenza vaccination was a cost-effective alternative to a full cohort analysisJ Clin Epidemiol200457987588015504630
   PubMed Web of Science ®Google Scholar
• de DiegoCVila-CorcolesAOchoaOEffects of annual influenza vaccination on winter mortality in elderly people with chronic heart diseaseEur Heart J200930220921618997178
   PubMed Web of Science ®Google Scholar
• CampitelliMARosellaLCStukelTAKwongJCInfluenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort studyVaccine201029224024621044667
   PubMed Web of Science ®Google Scholar
• MontoASHornbuckleKOhmitSEInfluenza vaccine effectiveness among elderly nursing home residents: a cohort studyAm J Epidemiol2001154215516011447049
   PubMed Web of Science ®Google Scholar
• NicholKLNordinJDNelsonDBMulloolyJPHakEEffectiveness of influenza vaccine in the community-dwelling elderlyN Engl J Med2007357141373138117914038
   PubMed Web of Science ®Google Scholar
• VuTFarishSJenkinsMKellyHA meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the communityVaccine20022013–141831183611906772
   PubMed Web of Science ®Google Scholar
• RivettiDJeffersonTThomasRVaccines for preventing influenza in the elderlyCochrane Database Syst Rev20063CD00487616856068
   PubMedGoogle Scholar
• JeffersonTRivettiDRivettiARudinMDi PietrantonjCDemicheliVEfficacy and effectiveness of influenza vaccines in elderly people: a systematic reviewLancet200536694921165117416198765
   PubMed Web of Science ®Google Scholar
• FioreAEShayDKBroderKPrevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008MMWR Recomm Rep200857RR–716018685555
   PubMedGoogle Scholar
• DeansGDStiverHGMcElhaneyJEInfluenza vaccines provide diminished protection but are cost-saving in older adultsJ Intern Med2010267222022720175868
   PubMed Web of Science ®Google Scholar
• MaciosekMVSolbergLICoffieldABEdwardsNMGoodmanMJInfluenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and olderAm J Prev Med2006311727916777545
   PubMed Web of Science ®Google Scholar
• JeffersonTInfluenza vaccination: policy versus evidenceBMJ2006333757491291517068038
   PubMed Web of Science ®Google Scholar
• FiremanBLeeJLewisNBembomOvan der LaanMBaxterRInfluenza vaccination and mortality: differentiating vaccine effects from biasAm J Epidemiol2009170565065619625341
   PubMed Web of Science ®Google Scholar
• SimonsenLViboudCTaylorRJMillerMAJacksonLInfluenza vaccination and mortality benefits: new insights, new opportunitiesVaccine200927456300630419840664
   PubMed Web of Science ®Google Scholar
• JacksonMLNelsonJCWeissNSNeuzilKMBarlowWJacksonLAInfluenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control studyLancet2008372963639840518675690
   PubMed Web of Science ®Google Scholar
• SimonsenLTaylorRJViboudCMillerMAJacksonLAMortality benefits of influenza vaccination in elderly people: an ongoing controversyLancet Infect Dis200771065866617897608
   PubMed Web of Science ®Google Scholar
• JeffersonTDi PietrantonjCRivettiABawazeerGAAl-AnsaryLAFerroniEVaccines for preventing influenza in healthy adultsCochrane Database Syst Rev20107CD00126920614424
   PubMed Web of Science ®Google Scholar
• SkowronskiDMTweedSADe SerresGRapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?J Infect Dis2008197449050218275271
   PubMed Web of Science ®Google Scholar
• FengJGulatiUZhangXAntibody quantity versus quality after influenza vaccinationVaccine200927456358636219840673
   PubMed Web of Science ®Google Scholar
• AnsaldiFBacilieriSDurandoPCross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza virusesVaccine200826121525152918294741
   PubMed Web of Science ®Google Scholar
• AnsaldiFZancolliMDurandoPAntibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolatesVaccine201028254123412920433807
   PubMed Web of Science ®Google Scholar
• PandaAQianFMohantySAge-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine responseJ Immunol201018452518252720100933
   PubMed Web of Science ®Google Scholar
• NuzumJPiloteIStanglFBonarBPandemic influenza and pneumonia in a large civilian hospitalJAMA19187115621565
   Google Scholar
• SchwarzmannSWAdlerJLSullivanRJJrMarineWMBacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969Arch Intern Med19711276103710415578560
   PubMedGoogle Scholar
• PalaciosGHornigMCisternaDStreptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenzaPloS One2009412e854020046873
   PubMed Web of Science ®Google Scholar
• McCullersJAInsights into the interaction between influenza virus and pneumococcusClin Microbiol Rev200619357158216847087
   PubMed Web of Science ®Google Scholar
• DiavatopoulosDAShortKRPriceJTInfluenza A virus facilitates Streptococcus pneumoniae transmission and diseaseFASEB J20102461789179820097876
   PubMed Web of Science ®Google Scholar
• MorensDMTaubenbergerJKFauciASPredominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparednessJ Infect Dis2008198796297018710327
   PubMed Web of Science ®Google Scholar
• ChristensonBHedlundJLundberghPOrtqvistAAdditive preventive effect of influenza and pneumococcal vaccines in elderly personsEur Respir J200423336336815065822
   PubMed Web of Science ®Google Scholar
• WeaverMKriegerJCastorinaJWallsMCiskeSCost-effectiveness of combined outreach for the pneumococcal and influenza vaccinesArch Intern Med2001161111112011146707
   PubMedGoogle Scholar
• CaiLUchiyamaHYanagisawaSKamaeICost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in JapanKobe J Med Sci2006523–49710916855372
   PubMedGoogle Scholar
• LambertLCFauciASInfluenza vaccines for the futureN Engl J Med2010363212036204421083388
   PubMed Web of Science ®Google Scholar
• NabelGJFauciASInduction of unnatural immunity: prospects for a broadly protective universal influenza vaccineNat Med201016121389139121135852
   PubMed Web of Science ®Google Scholar
• GiefingCMeinkeALHannerMDiscovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodiesJ Exp Med2008205111713118166586
   PubMed Web of Science ®Google Scholar
• LuYJLeiteLGoncalvesVMGMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsisVaccine201028477468747520858450
   PubMed Web of Science ®Google Scholar
• CateTRRayfordYNinoDA high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjectsVaccine20102892076207920044052
   PubMed Web of Science ®Google Scholar
• FalseyARTreanorJJTornieporthNCapellanJGorseGJRandomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and olderJ Infect Dis2009200217218019508159
   PubMed Web of Science ®Google Scholar
• De VilliersPJSteeleADHiemstraLAEfficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and olderVaccine200928122823419796721
   PubMed Web of Science ®Google Scholar
• HuckriedeABungenerLStegmannTThe virosome concept for influenza vaccinesVaccine200523Suppl 1S26S3816026906
   PubMed Web of Science ®Google Scholar
• BernsteinDIEdwardsKMDekkerCLEffects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adultsJ Infect Dis2008197566767518260764
   PubMed Web of Science ®Google Scholar
• ChuDWHwangSJLimFSImmunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adultsVaccine200927527428743519683087
   PubMed Web of Science ®Google Scholar
• JhaAKWrightSMPerlinJBPerformance measures, vaccinations, and pneumonia rates among high-risk patients in Veterans Administration health careAm J Public Health200797122167217217971554
   PubMed Web of Science ®Google Scholar